Go to the list of all blogs
M. Benett's Avatar
published in Blogs
Nov 05, 2026
TickeronGET DAILY SIGNALS
APLD vs HIVE: Weighing Two AI Infrastructure Stocks After -29% and -33% Declines

APLD vs HIVE: Weighing Two AI Infrastructure Stocks After -29% and -33% Declines

Key Takeaways

  • APLD operates as an AI data-center developer and operator with a roughly $36 billion contracted backlog, while HIVE runs a dual Bitcoin-mining and AI/high-performance-computing (HPC) business.
  • Both stocks have fallen sharply in recent weeks, but APLD shows relatively stronger fundamentals, including investment-grade tenants and recurring base rent growth.
  • HIVE carries greater sensitivity to Bitcoin prices, share dilution, and elevated financing costs tied to its GPU-cloud expansion.
  • Analyst consensus on both names skews bullish, though price targets imply materially wider upside dispersion for HIVE.
  • Tickeron AI Verdict: Between the two, the AI-driven comparison currently favors APLD based on trend consistency, contracted revenue visibility, and a more diversified customer base.
  • For more detail, explore APLD Major News and APLD Today's Price Move, plus HIVE Major News and HIVE Today's Price Move.
  • To see how automated strategies are navigating this market, explore the curated Trending AI Robots.

Why This Comparison Matters Now

Investors seeking exposure to the buildout of artificial-intelligence infrastructure often come across two distinct business models within the same broad theme. Applied Digital (APLD) develops and leases AI data-center capacity to cloud and hyperscaler customers, while HIVE Digital Technologies (HIVE) combines Bitcoin mining with a growing AI and HPC hosting segment. This side-by-side look is useful for traders assessing relative performance, positioning, and risk across digital infrastructure and crypto-adjacent sectors. Both names have shown notable volatility lately, so a direct review helps clarify where trend strength and stability currently stand.

Applied Digital Overview and Recent Performance

Applied Digital (APLD) builds and operates data centers tailored for AI and high-performance-computing workloads, then leases the capacity under long-term, take-or-pay agreements with tenants such as CoreWeave. Management frames the business as a technically focused real-estate operation rather than a neocloud provider. Recent results included a sharp 322% year-over-year revenue increase, although net losses widened amid higher interest expense from the debt-funded expansion.

Financing remains a point of attention, with management indicating that roughly 800 megawatts of additional capacity still requires funding over the next twelve months. The balance sheet shows about $6.4 billion in debt against $3.7 billion in cash. The stock has declined roughly 29% over the past month and sits below key moving averages. On the constructive side, the company highlights roughly $36 billion in contracted base-term revenue and plans to bring more than 600 MW online in the coming year. A new partnership for a wind-powered AI data center in Texas underscores ongoing project momentum. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

HIVE Overview and Recent Performance

HIVE Digital Technologies (HIVE) runs green-energy-powered data centers in Canada, Sweden, Paraguay, and Bermuda, pursuing a dual strategy of Bitcoin mining alongside an AI/HPC segment through its BUZZ HPC subsidiary. Recent focus has been on GPU-cloud growth, including roughly $129 million in three-year, 9% fixed-rate financing to acquire NVIDIA GB200 GPUs for a contract with AI customer Cohere, plus a prior five-year GPU-cloud agreement valued at approximately $350 million.

Even with these wins, the stock has faced pressure, dropping roughly 33% over the past month and trading near the lower end of its 52-week range. HIVE’s share price remains closely linked to Bitcoin movements, which adds volatility, while expansion has involved convertible and at-the-market equity programs that raise dilution considerations. Analysts generally hold a bullish consensus, though recent target adjustments have been mixed amid questions around financing costs and the conversion of signed AI contracts into recurring cash flow.

Head-to-Head Comparison

The companies diverge most clearly in business model and risk profile. APLD is a pure-play AI infrastructure developer with large, investment-grade tenants and long-duration leases, which supports clearer revenue visibility but also entails significant capital and debt commitments. HIVE blends Bitcoin mining with AI/HPC hosting, providing exposure to two demand areas while inheriting crypto price swings and equity-linked financing dilution.

On momentum, both have trended lower recently, though APLD has posted occasional sharp bounces around capacity milestones. HIVE’s smaller market capitalization and higher beta tend to amplify moves in either direction. Growth paths also differ: APLD depends on converting signed leases into powered capacity, while HIVE relies on deploying GPU clusters and maintaining Bitcoin-mining economics. Sector exposure presents another trade-off, with APLD focused on U.S. data-center buildout and HIVE spanning international green-energy sites with notable crypto sensitivity.

AI-Driven Verdict

Considering trend consistency, stability, catalysts, and relative positioning, the comparison currently leans toward APLD. The larger contracted-revenue backlog, investment-grade tenant base, and recurring base-rent growth offer a comparatively more stable foundation despite financing headwinds. HIVE provides higher optionality through its dual AI and Bitcoin exposure, yet that same structure brings greater volatility and dilution risk. The assessment is probabilistic rather than absolute: APLD’s relative consistency and visible demand pipeline currently edge out HIVE’s higher-beta profile in this matchup.

Using Tickeron AI Tools for Portfolio Insights

In my research process, I frequently review Tickeron’s AI Trading Bots to understand how automated strategies are positioned across volatile names like these. The platform offers a range of bots with different styles, timeframes, and performance statistics, helping me cross-check signals and historical data before making decisions. It adds a useful quantitative layer to the fundamental comparison without replacing careful analysis of the underlying businesses.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: HIVE, APLD

HIVE's MACD Histogram just turned positive

The Moving Average Convergence Divergence (MACD) for HIVE turned positive on November 04, 2026. Looking at past instances where HIVE's MACD turned positive, the stock continued to rise in 33 of 37 cases over the following month. The odds of a continued upward trend are 89%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where HIVE's RSI Oscillator exited the oversold zone, 34 of 41 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 83%.

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.

Following a +6.43% 3-day Advance, the price is estimated to grow further. Considering data from situations where HIVE advanced for three days, in 211 of 253 cases, the price rose further within the following month. The odds of a continued upward trend are 83%.

HIVE may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on October 01, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on HIVE as a result. In 67 of 80 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 84%.

HIVE moved below its 50-day moving average on October 05, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for HIVE crossed bearishly below the 50-day moving average on October 08, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 13 of 14 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.

The 50-day moving average for HIVE moved below the 200-day moving average on October 16, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where HIVE declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.

The Aroon Indicator for HIVE entered a downward trend on November 04, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 15 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 67 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.972) is normal, around the industry mean (3.123). P/E Ratio (9.174) is within average values for comparable stocks, (6.767). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (0.809). Dividend Yield (0.000) settles around the average of (9.201) among similar stocks. P/S Ratio (2.169) is also within normal values, averaging (16.899).

The Tickeron Price Growth Rating for this company is 89 (best 1 - 100 worst), indicating slightly worse than average price growth. HIVE’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. HIVE’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 87, placing this stock worse than average.

Notable companies

The most notable companies in this group are Morgan Stanley (NYSE:MS), Goldman Sachs Group (NYSE:GS), Charles Schwab Corp (The) (NYSE:SCHW), Gold.com Inc. (NYSE:GOLD).

Industry description

These banks specialize in underwriting (helping companies with debt financing or equity issuances), IPOs, facilitating mergers and other corporate reorganizations and acting as a broker or financial advisor for institutions. They might also trade securities on their own accounts. Investment banks potentially thrive on expanding its network of clients, since that could help them increase profits. Goldman Sachs, Morgan Stanley and CME Group Inc are some of the largest investment banking companies.

Market Cap

The average market capitalization across the Investment Banks/Brokers Industry is 11.75B. The market cap for tickers in the group ranges from 590 to 304.64B. MS holds the highest valuation in this group at 304.64B. The lowest valued company is FSSLD at 590.

High and low price notable news

The average weekly price growth across all stocks in the Investment Banks/Brokers Industry was -6%. For the same Industry, the average monthly price growth was -20%, and the average quarterly price growth was -24%. PMAX experienced the highest price growth at 114%, while AXG experienced the biggest fall at -70%.

Volume

The average weekly volume growth across all stocks in the Investment Banks/Brokers Industry was 26%. For the same stocks of the Industry, the average monthly volume growth was 49% and the average quarterly volume growth was -29%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 67
P/E Growth Rating: 66
Price Growth Rating: 68
SMR Rating: 74
Profit Risk Rating: 87
Seasonality Score: -11 (-100 ... +100)
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of cloud networking and enterprise Wi-Fi solution

Industry InvestmentBanksBrokers

Industry
Computer Communications
Address
7900 Callaghan Road
Phone
+1 604 664-1078
Employees
29
Web
https://www.hivedigitaltechnologies.com
Interact to see
Advertisement
The Bitwise Solana Staking ETF (BSOL) advanced roughly 18% over the trailing 30 days, closely tracking a sharp rally in Solana (SOL). The move extends a broader recovery, with BSOL up approximately 77% over the past three months from its mid-2026 trough.
MSTY is an actively managed single-stock option income ETF (exchange-traded fund) that writes call options on Strategy (MSTR), formerly MicroStrategy, to generate current income. The portfolio is anchored by U.S. Treasury bills and MSTR option contracts rather than a diversified basket of equities, concentrating exposure in one volatile underlying.
AMDL has surged roughly +64% over the past 30 days, from about $47.59 to $78.10, mirroring a powerful rally in its sole underlying stock, AMD . The fund is a leveraged single-stock ETF (exchange-traded fund) designed to deliver 2x the daily return of AMD, amplifying both gains and losses.
BIO shares plunged 10.12% to $251.77 from the previous close of $280.12. The selloff followed first-quarter 2026 earnings that included a $527.1 million net loss driven by a $738.2 million investment impairment.
Shares of DLB plunged 10.74% to $57.25 from the previous close of $64.14 during today's trading session. Primary catalyst: Negative market reaction to Q2 fiscal 2026 earnings results released after market close on April 30, despite beating EPS and revenue estimates.